Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies-Reference-Cited by-同舟云学术

Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies

Published:2018-02 Issue: Volume:48 Page:71-79
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Quinn Dean,Barnes Christopher N.,Yates Wayne,Bourdet David L.,Moran Edmund J.,Potgieter Peter,Nicholls Andrew,Haumann Brett,Singh Dave

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine

Reference25 articles.

1. Global burden of COPD;Lopez-Campos;Respirology,2016

2. Long-acting muscarinic receptor antagonists for the treatment of respiratory disease;Cazzola;Pulm. Pharmacol. Ther.,2013

3. Long-acting muscarinic antagonists;Melani;Expert Rev. Clin. Pharmacol.,2015

4. The importance of inhaler devices in the treatment of COPD;Bonini;COPD Res. Pract.,2015

5. Perceptions and attitudes toward the use of nebulized therapy for COPD: patient and caregiver perspectives;Sharafkhaneh;COPD,2013

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Muscarinic control of cardiovascular function in humans: a review of current clinical evidence;Clinical Autonomic Research;2024-02

2. Post Hoc Analysis of Lung Function Improvement and Patient-Reported Outcomes With Revefenacin in Adults With Moderate-to-Very Severe COPD and Comorbid Anxiety or Depression;Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation;2024

3. Joint longitudinal model-based meta-analysis of FEV1 and exacerbation rate in randomized COPD trials;Journal of Pharmacokinetics and Pharmacodynamics;2023-03-22

4. Pharmacokinetics, metabolite profiling, safety, and tolerability of inhalation aerosol of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, in healthy Chinese subjects;Frontiers in Pharmacology;2022-12-15

5. Human TMPRSS2 non-catalytic ectodomain and SARS-CoV-2 S2' subunit interaction mediated SARS-CoV-2 endocytosis: a model proposal with virtual screening for potential drug molecules to inhibit this interaction;Journal of Biomolecular Structure and Dynamics;2022-07-31